LEXX - Lexaria Bioscience Corp.
1.04
-0.040 -3.846%
Share volume: 81,735
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.08
-0.04
-0.04%
View ratios
| Fiscal Date | 11-30-2022 | 11-30-2023 | 05-31-2024 | 08-31-2024 | 11-30-2024 | 02-28-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q1 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 01-12-2024 | 01-10-2025 | 07-12-2024 | 01-10-2025 | 01-10-2025 | 04-14-2025 | |
| Total revenue | 97.735 K | 151.278 K | 84.000 K | 0.000 | 183.923 K | 174.000 K | |
| Cost of revenue | 15.795 K | 4.822 K | 0.000 | 0.000 | 2.720 K | 0.000 | |
| Gross profit | 81.940 K | 146.456 K | 84.000 K | 0.000 | 181.203 K | 174.000 K | |
| 78.74% | -42.64% | -100.00% | -3.98% | ||||
| Operating expenses | 1.777 M | 1.286 M | 1.827 M | 0.000 | 2.872 M | 2.925 M | |
| Selling general and admin | 947.870 K | 711.107 K | 1.254 M | 0.000 | 918.690 K | 1.239 M | |
| Research and development | 829.489 K | 574.491 K | 573.089 K | 0.000 | 1.953 M | 1.686 M | |
| Total expenses | 1.777 M | 1.286 M | 1.827 M | 0.000 | 2.888 M | 2.925 M | |
| -27.67% | 42.11% | -100.00% | 1.29% | ||||
| Operating income | -1.695 M | -1.139 M | -1.743 M | 0.000 | -2.691 M | -2.751 M | |
| Ebit | 0.000 | -1.192 M | -1.784 M | 0.000 | -2.707 M | -2.717 M | |
| Pretax income | -1.769 M | -1.185 M | -1.784 M | 0.000 | -2.707 M | -2.717 M | |
| -33.02% | 50.57% | -100.00% | 0.38% | ||||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.769 M | -1.185 M | -1.784 M | 0.000 | -2.707 M | -2.717 M | |
| 33.02% | -50.57% | 100.00% | -0.38% |
